Evidence map›Paper›PMID 31412611›Full record

ReviewInternational journal of molecular sciences2019

Fluorescence in Situ Hybridization (FISH) for Detecting Anaplastic Lymphoma Kinase (

Zhenya Tang, Lu Wang, Guilin Tang, L Jeffrey Medeiros

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zhenya TangDepartment of Hematopathogy/Clinical Cytogenetics Laboratory, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. ztang@mdanderson.org.
Lu WangDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Guilin TangDepartment of Hematopathogy/Clinical Cytogenetics Laboratory, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
L Jeffrey MedeirosDepartment of Hematopathogy/Clinical Cytogenetics Laboratory, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
The University of Texas MD Anderson Cancer Center · USSt. Jude Children's Research Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2011, the Vysis Break Apart ALK fluorescence in situ hybridization (FISH) assay was approved by the United States Food and Drug Administration as a companion diagnostic for detecting

Indexed as

Gene RearrangementIn Situ Hybridization, FluorescenceAlgorithmsAnaplastic Lymphoma KinaseBiomarkers, TumorGene AmplificationGene DosageHigh-Throughput Nucleotide SequencingHumansImmunohistochemistryLung NeoplasmsMutationALK protein, humanAnaplastic Lymphoma KinaseBiomarkers, TumorALKcutoff valuediscordant resultfluorescence in situ hybridization (FISH)immunohistochemistry (IHC)incidental findingnext generation sequencing (NGS)

Identifiers

PMID31412611
PMCPMC6720438
OpenAlexW2968137467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.